Senate Bill 0025
| || |
DIGEST OF SB25 (Updated February 22, 2011 5:08 pm - DI 84)
Study of pharmacy issues. Requires the health finance commission to study during the 2011 legislative interim the following : (1) Whether a pharmacist should be required to notify the prescribing physician and inform the patient if the pharmacist selects a drug other than the brand name drug listed on an antiepileptic drug prescription; and (2) Whether a pharmacist should be required to dispense a prescription in a manner to allow label accessibility to an individual who is blind.
>Latest Printing > (PDF)
Conference Committee Reports